insertion/deletion polymorphism (rs1799752) modifies the renoprotective effect of renin-angiotensin system blockade in patients with IgA nephropathy

insertion/deletion polymorphism (rs1799752) modifies the renoprotective effect of renin-angiotensin system blockade in patients with IgA nephropathy

Introduction: Little is known about genetic predictors that modify the renoprotective effect of renin-angiotensin system (RAS) blockade in IgA nephropathy (IgAN). Materials and methods: The present multicenter retrospective observational study examined effect modification between RAS blockade and th...

Full description

Bibliographic Details
Main Authors:	Junya Teranishi, Ryohei Yamamoto, Yasuyuki Nagasawa, Tatsuya Shoji, Hirotsugu Iwatani, Noriyuki Okada, Toshiki Moriyama, Atsushi Yamauchi, Yoshiharu Tsubakihara, Enyu Imai, Hiromi Rakugi, Yoshitaka Isaka
Format:	Article
Language:	English
Published:	SAGE Publications 2015-09-01
Series:	Journal of the Renin-Angiotensin-Aldosterone System
Online Access:	https://doi.org/10.1177/1470320313515036

Similar Items

Periodontal disease bacteria specific to tonsil in IgA nephropathy patients predicts the remission by the treatment.
by: Yasuyuki Nagasawa, et al.
Published: (2014-01-01)

A pilot study of the effects of eplerenone add-on therapy in patients taking renin–angiotensin system blockers
by: Noritaka Kawada, et al.
Published: (2015-06-01)

Optimal proteinuria target for renoprotection in patients with IgA nephropathy.
by: Ki Heon Nam, et al.
Published: (2014-01-01)

Which strategy in inhibition of the renin-angiotensin system is the most efficient for heart failure?
by: Toshio Ogihara, et al.
Published: (2008-09-01)

Renoprotective effects of the direct renin inhibitor aliskiren on gentamicin-induced nephrotoxicity in rats
by: Eun Hui Bae, et al.
Published: (2014-12-01)

IFI27 Is a Useful Genetic Marker for Diagnosis of Immunoglobulin A Nephropathy and Membranous Nephropathy Using Peripheral Blood.
by: Yasuyuki Nagasawa, et al.
Published: (2016-01-01)

Renoprotection in Type 2 diabetes: blockade of the renin-angiotensin system with angiotensin II receptor blockers
by: Pauline A Swift, et al.
Published: (2001-09-01)

Renoprotection, renin inhibition, and blood pressure control: the impact of aliskiren on integrated blood pressure control
by: Haroon-Ur Rashid
Published: (2010-10-01)

New Approaches to Blockade of the Renin–Angiotensin–Aldosterone System: Mineralocorticoid-Receptor Blockers Exert Antihypertensive and Renoprotective Effects Independently of the Renin–Angiotensin System
by: Akira Nishiyama, et al.
Published: (2010-01-01)

Between-patient differences in the renal response to renin-angiotensin system intervention: clue to optimising renoprotective therapy?
by: Gozewijn D Laverman, et al.
Published: (2002-12-01)

Magnesium modifies the cardiovascular mortality risk associated with hyperphosphatemia in patients undergoing hemodialysis: a cohort study.
by: Yusuke Sakaguchi, et al.
Published: (2014-01-01)

Renoprotective Effect of the Combination of Renin-angiotensin System Inhibitor and Calcium Channel Blocker in Patients with Hypertension and Chronic Kidney Disease
by: Rong-Shuang Huang, et al.
Published: (2016-01-01)

Inhibition of (pro)renin Receptor Contributes to Renoprotective Effects of Angiotensin II Type 1 Receptor Blockade in Diabetic Nephropathy
by: Lin Zhang, et al.
Published: (2017-10-01)

The <i>ACE</i> rs1799752 Variant Is Associated with COVID-19 Severity but Is Independent of Serum ACE Activity in Hospitalized and Recovered Patients
by: Ingrid Fricke-Galindo, et al.
Published: (2023-04-01)

Renoprotective effects of telmisartan in the 5/6 nephrectomised rats
by: Ichiro Tsunenari, et al.
Published: (2007-06-01)

The renoprotective effects of sulodexide
by: Olde Engberink RH, et al.
Published: (2016-03-01)

Supportive Management of IgA Nephropathy With Renin-Angiotensin Blockade, the AIIMS Primary IgA Nephropathy Cohort (APPROACH) Study
by: Soumita Bagchi, et al.
Published: (2021-06-01)

Association of ACE1 I/D rs1799752 and ACE2 rs2285666 polymorphisms with the infection and severity of COVID‐19: A meta‐analysis
by: Md. Abdul Aziz, et al.
Published: (2022-11-01)

Effect of ACE1 polymorphism rs1799752 on protein levels of ACE2, the SARS-CoV-2 entry receptor, in alveolar lung epithelium
by: Merel Jacobs, et al.
Published: (2021-04-01)

Variations in Urinary Renin-Angiotensin-Aldosterone Component Concentrations in Paediatric IgA Vasculitis Nephritis
by: Andrew J. Chetwynd, et al.
Published: (2022-12-01)

Use of low-dose sulodexide in IgA nephropathy patients on renin–angiotensin system blockades
by: Byeong Yun Yang, et al.
Published: (2012-09-01)

Combined Inhibition of Soluble Epoxide Hydrolase and Renin-Angiotensin System Exhibits Superior Renoprotection to Renin-Angiotensin System Blockade in 5/6 Nephrectomized Ren-2 Transgenic Hypertensive Rats with Established Chronic Kidney Disease
by: Věra Čertíková Chábová, et al.
Published: (2018-03-01)

Renoprotective potential of concomittant medications with SGLT2 inhibitors and renin-angiotensin system inhibitors in diabetic nephropathy without albuminuria: a retrospective cohort study
by: Tatsuya Ishibashi, et al.
Published: (2023-09-01)

cnm-positive Streptococcus mutans is associated with galactose-deficient IgA in patients with IgA nephropathy.
by: Taro Misaki, et al.
Published: (2023-01-01)

cnm-positive Streptococcus mutans is associated with galactose-deficient IgA in patients with IgA nephropathy
by: Taro Misaki, et al.
Published: (2023-01-01)

Renoprotection by long‐term low‐dose tolvaptan in patients with heart failure and hyponatremia
by: Tatsufumi Oka, et al.
Published: (2021-12-01)

BETA-BLOCKERS AND RENOPROTECTION: THE POTENTIAL OF CARVEDILOL
by: I. T. Murkamilov, et al.
Published: (2017-07-01)

PERINDOPRIL: THE POSSIBILITY OF ANTIHYPERTENSIVE AND RENOPROTECTIVE THERAPY
by: O. V. Dralova, et al.
Published: (2016-01-01)

Renoprotective Effects of DPP-4 Inhibitors
by: Daiji Kawanami, et al.
Published: (2021-02-01)

Nitric Oxide: Renoprotective in Cardiac Surgery!
by: Rohan Magoon, et al.
Published: (2020-06-01)

Pentoxifylline: Evidence strong enough for renoprotection?
by: Tai-Shuan Lai, et al.
Published: (2016-08-01)

Renoprotective effect of calcium channel blockers
by: Dimković Nada, et al.
Published: (2009-01-01)

Renoprotective effects of teneligliptin: An observational study
by: Prabhat Agrawal, et al.
Published: (2021-01-01)

Renoprotection with indapamide, additional feature to look for
by: Arindam Pande
Published: (2017-03-01)

Renoprotective effect of tolvaptan in patients with new‐onset acute heart failure
by: Hiromi Kin, et al.
Published: (2020-08-01)

Secondary Publication: Clinical Grade of IgA Nephropathy
by: Takahito Moriyama, et al.
Published: (2020-03-01)

Association Between Galactose-Deficient IgA1 Derived From the Tonsils and Recurrence of IgA Nephropathy in Patients Who Underwent Kidney Transplantation
by: Mayuko Kawabe, et al.
Published: (2020-09-01)

IgA nephropathy with early kidney disease is associated with increased arterial stiffness and renin–angiotensin system activity
by: A Abdi-Ali, et al.
Published: (2015-09-01)

Renoprotective impact of angiotensin 1-7: Is it certain?
by: Mehdi Nematbakhsh
Published: (2019-01-01)

Renoprotective impact of allopurinol in elderly patients with hypertension
by: Peyman Mottaghi
Published: (2018-04-01)